| Product Code: ETC9942473 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Dermatological OTC Drugs Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Dermatological OTC Drugs Market - Industry Life Cycle |
3.4 United Kingdom (UK) Dermatological OTC Drugs Market - Porter's Five Forces |
3.5 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume Share, By Rote of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Dermatological OTC Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about skin health and self-care among consumers |
4.2.2 Growing prevalence of skin conditions such as eczema, acne, and psoriasis |
4.2.3 Preference for over-the-counter (OTC) products due to convenience and accessibility |
4.3 Market Restraints |
4.3.1 Stringent regulations and approvals required for OTC drugs in the UK |
4.3.2 Competition from prescription-based dermatological products |
4.3.3 Limited insurance coverage for OTC dermatological drugs |
5 United Kingdom (UK) Dermatological OTC Drugs Market Trends |
6 United Kingdom (UK) Dermatological OTC Drugs Market, By Types |
6.1 United Kingdom (UK) Dermatological OTC Drugs Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Acne, 2021- 2031F |
6.1.4 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Dermatitis, 2021- 2031F |
6.1.5 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.1.6 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Fungal Infections, 2021- 2031F |
6.1.7 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Dermatological OTC Drugs Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2.3 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Capsules, 2021- 2031F |
6.2.4 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Oils, 2021- 2031F |
6.2.5 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Gets, 2021- 2031F |
6.2.6 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Creams, 2021- 2031F |
6.2.7 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Ointments, 2021- 2031F |
6.3 United Kingdom (UK) Dermatological OTC Drugs Market, By Rote of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Topical, 2021- 2031F |
6.4 United Kingdom (UK) Dermatological OTC Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4.5 United Kingdom (UK) Dermatological OTC Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Dermatological OTC Drugs Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Dermatological OTC Drugs Market Export to Major Countries |
7.2 United Kingdom (UK) Dermatological OTC Drugs Market Imports from Major Countries |
8 United Kingdom (UK) Dermatological OTC Drugs Market Key Performance Indicators |
8.1 Number of dermatological OTC drug launches in the UK market |
8.2 Consumer satisfaction and loyalty towards dermatological OTC products |
8.3 Growth in the number of dermatology clinics and skincare centers offering OTC products |
8.4 Increase in dermatologist recommendations for OTC products |
8.5 Trends in online searches and social media mentions related to dermatological OTC drugs in the UK |
9 United Kingdom (UK) Dermatological OTC Drugs Market - Opportunity Assessment |
9.1 United Kingdom (UK) Dermatological OTC Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 United Kingdom (UK) Dermatological OTC Drugs Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 United Kingdom (UK) Dermatological OTC Drugs Market Opportunity Assessment, By Rote of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Dermatological OTC Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Dermatological OTC Drugs Market - Competitive Landscape |
10.1 United Kingdom (UK) Dermatological OTC Drugs Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Dermatological OTC Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here